|
Volumn 23, Issue 5, 2000, Pages 262-266
|
A comparison of dopamine agonists and catechol-O-methyltransferase inhibitors in Parkinson's disease
a,b a c a |
Author keywords
COMT inhibitor; Dopamine agonist; Double blind study; Meta analysis; Motor fluctuation; Odds ratio; Parkinson's disease; Therapy
|
Indexed keywords
CATECHOL METHYLTRANSFERASE INHIBITOR;
DOPAMINE RECEPTOR STIMULATING AGENT;
ENTACAPONE;
LEVODOPA;
PERGOLIDE;
PLACEBO;
PRAMIPEXOLE;
ROPINIROLE;
TOLCAPONE;
ADD ON THERAPY;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG TOLERABILITY;
DYSKINESIA;
HUMAN;
META ANALYSIS;
MULTICENTER STUDY;
PARKINSON DISEASE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
STATISTICAL ANALYSIS;
CATECHOL O-METHYLTRANSFERASE;
CHI-SQUARE DISTRIBUTION;
CONFIDENCE INTERVALS;
CONTROLLED CLINICAL TRIALS;
DOPAMINE AGENTS;
DOPAMINE AGONISTS;
DYSKINESIA, DRUG-INDUCED;
HUMANS;
LEVODOPA;
ODDS RATIO;
PARKINSON DISEASE;
|
EID: 0034538302
PISSN: 03625664
EISSN: None
Source Type: Journal
DOI: 10.1097/00002826-200009000-00004 Document Type: Article |
Times cited : (19)
|
References (10)
|